Amalgamated Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,510
| Closed | -$102K | – | 3019 |
|
|
2023
Q3 | $102K | Buy |
5,510
+1,736
| +46% | +$19.6K | ﹤0.01% | 1992 |
|
|
2023
Q2 | $42K | Buy |
3,774
+335
| +10% | +$4.67K | ﹤0.01% | 2402 |
|
|
2023
Q1 | $46K | Sell |
3,439
-512
| -13% | -$8.86K | ﹤0.01% | 2340 |
|
|
2022
Q4 | $49K | Hold |
3,951
| – | – | ﹤0.01% | 2425 |
|
|
2022
Q3 | $55K | Buy |
3,951
+60
| +2% | +$966 | ﹤0.01% | 2417 |
|
|
2022
Q2 | $54K | Sell |
3,891
-187
| -5% | -$2.99K | ﹤0.01% | 2441 |
|
|
2022
Q1 | $66K | Buy |
+4,078
| New | +$63.9K | ﹤0.01% | 2340 |
|
|
2020
Q2 | – | Sell |
-4,512
| Closed | -$284K | – | 1685 |
|
|
2020
Q1 | $284K | Sell |
4,512
-189
| -4% | -$17K | 0.01% | 1177 |
|
|
2019
Q4 | $583K | Buy |
4,701
+319
| +7% | +$28.6K | 0.01% | 1043 |
|
|
2019
Q3 | $291K | Sell |
4,382
-63
| -1% | -$4.23K | 0.01% | 1338 |
|
|
2019
Q2 | $354K | Buy |
4,445
+1,117
| +34% | +$100K | 0.01% | 1255 |
|
|
2019
Q1 | $372K | Buy |
3,328
+132
| +4% | +$14.4K | 0.01% | 1144 |
|
|
2018
Q4 | $322K | Buy |
+3,196
| New | +$331K | 0.01% | 1139 |
|
|
2018
Q3 | – | Sell |
-3,337
| Closed | -$280K | – | 1649 |
|
|
2018
Q2 | $280K | Sell |
3,337
-494
| -13% | -$36.2K | 0.01% | 1365 |
|
|
2018
Q1 | $236K | Buy |
3,831
+247
| +7% | +$14.9K | 0.01% | 1361 |
|
|
2017
Q4 | $209K | Buy |
+3,584
| New | +$226K | 0.01% | 1483 |
|
|
2017
Q3 | – | Sell |
-3,226
| Closed | -$391K | – | 1607 |
|
|
2017
Q2 | $391K | Buy |
3,226
+830
| +35% | +$96.1K | 0.01% | 1056 |
|
|
2017
Q1 | $271K | Sell |
2,396
-531
| -18% | -$62K | 0.01% | 1204 |
|
|
2016
Q4 | $318K | Buy |
2,927
+307
| +12% | +$36.6K | 0.01% | 1101 |
|
|
2016
Q3 | $431K | Buy |
2,620
+1
| +0% | +$158 | 0.03% | 813 |
|
|
2016
Q2 | $413K | Buy |
2,619
+735
| +39% | +$107K | 0.02% | 831 |
|
|
2016
Q1 | $242K | Buy |
1,884
+146
| +8% | +$17.2K | 0.02% | 1017 |
|
|
2015
Q4 | $260K | Sell |
1,738
-123
| -7% | -$20.8K | 0.03% | 878 |
|
|
2015
Q3 | $309K | Buy |
1,861
+24
| +1% | +$5.28K | 0.03% | 864 |
|
|
2015
Q2 | $443K | Buy |
1,837
+339
| +23% | +$90.3K | 0.04% | 650 |
|
|
2015
Q1 | $422K | Buy |
1,498
+137
| +10% | +$29.7K | 0.05% | 495 |
|
|
2014
Q4 | $212K | Buy |
1,361
+7
| +0.5% | +$1.29K | 0.03% | 773 |
|
|
2014
Q3 | $320K | Buy |
1,354
+11
| +0.8% | +$2.8K | 0.05% | 556 |
|
|
2014
Q2 | $318K | Buy |
1,343
+606
| +82% | +$160K | 0.05% | 568 |
|
|
2014
Q1 | $243K | Buy |
+737
| New | +$249K | 0.04% | 672 |
|
Amalgamated Bank's ICPT Position: Q4 2023 in Review
Amalgamated Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 5,510 shares — an estimated $102K sold.
Amalgamated Bank first reported a position in ICPT in Q1 2014 and held it in 30 quarters. The position peaked at $583K in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Amalgamated Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Amalgamated Bank sold 5,510 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $102K.
- Amalgamated Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 30 quarters.
- Amalgamated Bank's Intercept Pharmaceuticals, Inc. position peaked at $583K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Amalgamated Bank's 13F filing for Q4 2023, filed 6 Feb 2024.